- A historical liver biopsy within 12 months of screening consistent with NASH (defined as the presence of steatosis, inflammation, and ballooning) with stage 2-3 fibrosis according to the NASH Clinical Research Network (CRN) classification (or equivalent) and no documented weight loss > 5% between the date of the liver biopsy and screening